Skip to main content
. 2015 Sep 19;5(3):435–441. doi: 10.15171/apb.2015.059

Figure 6.

Figure 6

X-ray diffraction (XRD) patterns of PEG and Spironolactone preparations

a: PEG, b: Spironolactone, c: Physical mixture (1:1 Drug-carrier), d: Solid dispersion (1:1 Drug-carrier), e: Solid dispersion (1:1 Drug-carrier and 1.5% Tween 80), f: Solid dispersion (1:1 Drug-carrier and 1.5% Tween 60)